Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Yasushi Horimasu (Hiroshima, Japan), Yasushi Horimasu, Nobuhisa Ishikawa, Sonosuke Tanaka, Hiroshi Iwamoto, Shinichiro Ohshimo, Kazunori Fujitaka, Noboru Hattori, Hironobu Hamada, Nobuoki Kohno. MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma. Eur Respir J 2015; 46: Suppl. 59, 4237

Member's Comments

No comment yet.

Related content which might interest you: Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Serum osteopontin as a prognostic marker in patients with lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Polymorphism of HLA-G gene promotor in patients with non small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Expression of interleukin-18 and interleukin-18 receptor mRNA in lung tissue samples from non small lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Association between leptin and risk of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 The prognostic impact of PD1 and PDL1 expression in non-small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Frequency and type of EGFR mutations in patients with adenocarcinoma of the lung Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 The evaluation of biological and clinical significance of alpha-1 antitrypsin in non-small cell lung cancer Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Expression and clinical significance of S100 calcium binding protein A2 in lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015